Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NHGRI

Encapsulated N-Acetylmannosamine or N-Acetylneuraminic Acid to Increase Sialylation

  • Read more about Encapsulated N-Acetylmannosamine or N-Acetylneuraminic Acid to Increase Sialylation
US Application 13/605,946
Filed on 2012-09-06

Adenosine Receptor Agonists For The Treatment And Prevention Of Vascular Or Joint Capsule Calcification Disorders

  • Read more about Adenosine Receptor Agonists For The Treatment And Prevention Of Vascular Or Joint Capsule Calcification Disorders
US Application 13/582,035
Filed on 2012-08-30

Method Of Treating Pathologic Heterotopic Ossification

  • Read more about Method Of Treating Pathologic Heterotopic Ossification
Patent Cooperation Treaty
PCT/US12/044613
Filed on 2012-06-28

Methods For Detecting ADHD Susceptibility And Predicting Severity Ans Long Term Outcome of ADHD Symptoms

  • Read more about Methods For Detecting ADHD Susceptibility And Predicting Severity Ans Long Term Outcome of ADHD Symptoms
US Application 13/475,342
Filed on 2012-05-18

ACSF3 Mutations In Metabolic Disorders

  • Read more about ACSF3 Mutations In Metabolic Disorders
Patent Cooperation Treaty
PCT/US12/44926
Filed on 2012-06-29

METHODS FOR ANALYZING HIGH DIMENSIONAL DATA FOR CLASSIFYING DIAGNOSING PROGNOSTICATING AND/OR PREDICTING DISEASES AND OTHER BIOLOGICAL STATES

  • Read more about METHODS FOR ANALYZING HIGH DIMENSIONAL DATA FOR CLASSIFYING DIAGNOSING PROGNOSTICATING AND/OR PREDICTING DISEASES AND OTHER BIOLOGICAL STATES
US Patent 8,620,592
Filed on 2011-10-31

Methods For Treating Leukemia And Disorders Mediated By CBFBETA And RUNX1 Proteins

  • Read more about Methods For Treating Leukemia And Disorders Mediated By CBFBETA And RUNX1 Proteins
Patent Cooperation Treaty
PCT/US2012/029169
Filed on 2012-03-15

SELECTIONS OF GENES AND METHODS OF USING THE SAME FOR DIAGNOSIS AND FOR TARGETING THE THERAPY OF SELECT CANCERS

  • Read more about SELECTIONS OF GENES AND METHODS OF USING THE SAME FOR DIAGNOSIS AND FOR TARGETING THE THERAPY OF SELECT CANCERS
US Patent 8,065,092
Filed on 2010-08-18

TRRAP AND GRIN2A MUTATIONS AND USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF MELANOMA

  • Read more about TRRAP AND GRIN2A MUTATIONS AND USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF MELANOMA
Patent Cooperation Treaty
PCT/US2012/022687
Filed on 2012-01-26

LMNA GENE AND ITS INVOLVEMENT IN HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS) AND ARTERIOSCLEROSIS

  • Read more about LMNA GENE AND ITS INVOLVEMENT IN HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS) AND ARTERIOSCLEROSIS
US Patent 8,535,884
Filed on 2011-09-09

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • …
  • Next page ››
  • Last page Last »
Subscribe to NHGRI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health